Aetna (AET) Receives $190.75 Average PT from Analysts

Aetna (NYSE:AET) has earned a consensus rating of Buy from the twenty-one ratings firms that are currently covering the company, Marketbeat.com reports. Nine analysts have rated the stock with a hold recommendation and twelve have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $190.75.

A number of research analysts recently issued reports on AET shares. Credit Suisse Group raised their price objective on shares of Aetna from $200.00 to $208.00 and gave the company a neutral rating in a report on Wednesday, January 31st. Jefferies Group restated a hold rating and set a $205.00 price target on shares of Aetna in a report on Wednesday, January 31st. Cowen restated a buy rating and set a $212.00 price target on shares of Aetna in a report on Tuesday, January 30th. Piper Jaffray restated a buy rating and set a $212.00 price target on shares of Aetna in a report on Tuesday, January 30th. Finally, Citigroup lowered shares of Aetna from a buy rating to a neutral rating and raised their price target for the stock from $187.89 to $212.00 in a report on Wednesday, January 31st.

NYSE AET traded down $0.41 during trading hours on Thursday, reaching $178.64. The companys stock had a trading volume of 1,055,231 shares, compared to its average volume of 2,430,425. The firm has a market cap of $58,810.42, a PE ratio of 18.15, a price-to-earnings-growth ratio of 1.45 and a beta of 0.67. Aetna has a 52 week low of $135.61 and a 52 week high of $194.40. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.65 and a quick ratio of 0.65.

Aetna (NYSE:AET) last issued its quarterly earnings data on Tuesday, May 1st. The company reported $3.19 earnings per share (EPS) for the quarter, beating analysts consensus estimates of $2.97 by $0.22. The business had revenue of $15.34 billion during the quarter, compared to analyst estimates of $15.32 billion. Aetna had a net margin of 3.15% and a return on equity of 21.50%. The firms quarterly revenue was up 1.1% on a year-over-year basis. During the same quarter last year, the business earned $2.71 EPS. research analysts anticipate that Aetna will post 11.02 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 27th. Stockholders of record on Thursday, April 12th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.12%. The ex-dividend date was Wednesday, April 11th. Aetnas dividend payout ratio (DPR) is 20.28%.

Several hedge funds have recently made changes to their positions in AET. Focused Wealth Management Inc grew its position in shares of Aetna by 84.5% during the 4th quarter. Focused Wealth Management Inc now owns 655 shares of the companys stock worth $118,000 after buying an additional 300 shares during the period. Cerebellum GP LLC acquired a new stake in shares of Aetna during the 4th quarter worth approximately $125,000. James Hambro & Partners acquired a new stake in shares of Aetna during the 4th quarter worth approximately $158,000. Harel Insurance Investments & Financial Services Ltd. acquired a new stake in shares of Aetna during the 4th quarter worth approximately $180,000. Finally, Signature Estate & Investment Advisors LLC acquired a new stake in shares of Aetna during the 4th quarter worth approximately $182,000. 87.00% of the stock is owned by institutional investors.

This article provided by NewsEdge.